Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
NCT00515255 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2012-04-27
Summary
The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.
Conditions
- Obsessive Compulsive Disorder
Interventions
- DRUG
-
Minocycline
Capsules
Sponsors & Collaborators
-
Neuropharm
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
Countries
- United States
Study Locations
More Related Trials
-
Characterization of Childhood-Onset Obsessive-Compulsive Disorder
NCT00044239 ·Status: COMPLETED
-
N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
NCT01172275 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
NCT01933919 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
NCT01108393 ·Status: COMPLETED ·Phase: PHASE2
-
Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD)
NCT02160431 ·Status: TERMINATED ·Phase: NA
-
Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)
NCT02422290 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Overlapping Neural Circuits in Pediatric OCD
NCT02421315 ·Status: COMPLETED ·Phase: NA
-
Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
NCT00004310 ·Status: UNKNOWN ·Phase: PHASE2
-
Tolcapone in Obsessive Compulsive Disorder
NCT03348930 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Obsessive-Compulsive Disorder
NCT00000373 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Obsessive Compulsive Disorder in Children
NCT00074815 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
NCT01275248 ·Status: TERMINATED ·Phase: PHASE2
-
A Controlled Trial of Daily Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
NCT00369642 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
NCT03356483 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Behavioral Group Treatment for Obsessive-compulsive Disorder in Youth
NCT04891367 ·Status: UNKNOWN ·Phase: NA
-
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
NCT00211744 ·Status: COMPLETED ·Phase: PHASE4
-
Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)
NCT01194076 ·Status: COMPLETED ·Phase: NA
-
Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
NCT00956085 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
NCT03239210 ·Status: COMPLETED ·Phase: PHASE4
-
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
NCT00254735 ·Status: COMPLETED ·Phase: PHASE3
-
Fluoxetine in Pediatric Body Dysmorphic Disorder
NCT00245635 ·Status: COMPLETED ·Phase: PHASE4
-
Using Personalized Assessments in the Treatment of Childhood OCD
NCT06407648 ·Status: RECRUITING ·Phase: NA
-
Adjunctive Celecoxib in Childhood-onset OCD Study
NCT04673578 ·Status: UNKNOWN ·Phase: PHASE2
-
N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
NCT00539513 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment Youth With Obsessive-Compulsive Disorder
NCT00708240 ·Status: UNKNOWN ·Phase: PHASE4